| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 340,7 k € | +7.0% | 318,4 k € | +15.9% | 274,8 k € | +22.0% | 225,3 k € | +15.4% | 195,2 k € | -2.8% | 200,7 k € | +4.2% | 192,6 k € | +699.8% | 24,1 k € | -45.8% | 44,4 k € | -41.2% | 75,6 k € | +139.3% | 31,6 k € | -46.8% | 59,4 k € | +1.6% | 58,5 k € | +0.3% | 58,3 k € | +14.7% | 50,8 k € | +2.5% | 49,6 k € | +545.8% | 7,7 k € | -51.9% | 16,0 k € | -64.7% | 45,3 k € | |
| EBITDA | 339,4 k € | +6.8% | 317,9 k € | +16.0% | 274,2 k € | +22.3% | 224,2 k € | +15.6% | 194,1 k € | -2.5% | 198,9 k € | +7.2% | 185,6 k € | +839.4% | 19,8 k € | -55.4% | 44,3 k € | -27.1% | 60,7 k € | +101.8% | 30,1 k € | -46.8% | 56,6 k € | +0.6% | 56,3 k € | +60.5% | 35,1 k € | +6.5% | 32,9 k € | -33.0% | 49,1 k € | +578.4% | 7,2 k € | -38.8% | 11,8 k € | -71.5% | 41,5 k € | |
| Operating profit | 300,7 k € | +3.3% | 291,2 k € | +12.0% | 260,0 k € | +23.4% | 210,7 k € | +22.5% | 172,0 k € | -5.7% | 182,4 k € | +8.1% | 168,8 k € | +8876.4% | 1,9 k € | -93.1% | 27,1 k € | -38.2% | 43,9 k € | +215.8% | 13,9 k € | -65.5% | 40,3 k € | +2.4% | 39,3 k € | +128.8% | 17,2 k € | +61.9% | 10,6 k € | -68.0% | 33,1 k € | +1315.5% | -2,7 k € | +28.7% | -3,8 k € | -115.9% | 24,0 k € | |
| Profit/loss | 204,0 k € | +3.4% | 197,4 k € | +11.2% | 177,5 k € | +22.4% | 145,0 k € | +23.2% | 117,7 k € | +0.7% | 116,9 k € | +4.8% | 111,5 k € | +1889.4% | 5,6 k € | -75.1% | 22,5 k € | -12.3% | 25,7 k € | +111.2% | 12,1 k € | -60.8% | 31,0 k € | +3.7% | 29,9 k € | +157.5% | 11,6 k € | +171.1% | 4,3 k € | -85.3% | 29,0 k € | +373.7% | -10,6 k € | -2317.3% | 478,3 € | -96.7% | 14,4 k € | |
| Equity | 1,1 M € | +22.7% | 899,1 k € | +4.3% | 861,7 k € | +25.9% | 684,2 k € | +26.9% | 539,2 k € | +29.3% | 417,0 k € | +38.9% | 300,2 k € | +59.1% | 188,7 k € | +3.1% | 183,1 k € | +14.0% | 160,6 k € | +19.0% | 134,9 k € | +9.9% | 122,8 k € | +33.7% | 91,8 k € | +48.2% | 61,9 k € | +11.9% | 55,4 k € | +8.4% | 51,1 k € | +131.6% | 22,1 k € | +16.9% | 18,9 k € | +2.6% | 18,4 k € | |
| Total assets | 1,1 M € | +1.8% | 1,1 M € | +26.0% | 879,0 k € | +24.7% | 704,6 k € | +15.8% | 608,4 k € | +36.2% | 446,7 k € | +28.1% | 348,8 k € | +47.5% | 236,4 k € | +0.1% | 236,0 k € | -3.2% | 243,8 k € | +28.0% | 190,4 k € | -5.8% | 202,0 k € | +16.2% | 173,8 k € | +18.4% | 146,8 k € | +13.1% | 129,8 k € | +22.9% | 105,6 k € | +58.5% | 66,6 k € | -7.0% | 71,7 k € | -10.6% | 80,2 k € | |
| Cash | 1,0 M € | +15.3% | 888,1 k € | +14.0% | 778,9 k € | +25.9% | 618,5 k € | +29.2% | 478,8 k € | +86.9% | 256,2 k € | +76.9% | 144,8 k € | +530.5% | 23,0 k € | -59.3% | 56,4 k € | -16.2% | 67,3 k € | +105.5% | 32,7 k € | -12.8% | 37,6 k € | -43.5% | 66,4 k € | +124.6% | 29,6 k € | +2200.0% | 1,3 k € | -6.5% | 1,4 k € | +295.0% | 348,2 € | -84.0% | 2,2 k € | +38.9% | 1,6 k € | |
| Debts | 24,6 k € | -88.2% | 208,1 k € | +1100.4% | 17,3 k € | -15.1% | 20,4 k € | -70.5% | 69,2 k € | +133.7% | 29,6 k € | -39.1% | 48,6 k € | +174.4% | 17,7 k € | -22.9% | 23,0 k € | -56.8% | 53,2 k € | +108.5% | 25,5 k € | -48.2% | 49,3 k € | -5.3% | 52,0 k € | -5.2% | 54,9 k € | -14.9% | 64,5 k € | +18.1% | 54,6 k € | +22.4% | 44,6 k € | -15.6% | 52,8 k € | -14.6% | 61,8 k € | |
Private limited company profitable and well capitalised. Cash position rising (+15.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. A. VAN ERCK is a Private limited company incorporated in 2003. Its main activity is: Veterinary activities. Its registered office is in Hoogstraten.
Source: Belgian Official Gazette
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.